MALAT1 acts as oncogenic lncRNA in a wide variety of solid and hematological malignancies, including osteosarcoma [28], renal cell carcinoma [29], colorectal [43], prostate cancer [30], esophageal carcinoma [44], T, NK [45] and mantle cell lymphomas [46]. Here, MALAT1 is linked to renal cell carcinoma.